These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9102961)

  • 1. [Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?].
    Leren TP; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):681-3. PubMed ID: 9102961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
    Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A family-based strategy for diagnosing familial hypercholesterolemia].
    Leren TP; Manshaus T; Ose L
    Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial hypercholesterolemia: do we know how to diagnose it correctly?].
    Soska V
    Vnitr Lek; 2000 Jan; 46(1):19-23. PubMed ID: 10953659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations and genetherapy. Clinical genetics of familial hypercholesterolemia.
    Schuster H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():4-5. PubMed ID: 8767443
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology.
    Bates TR; Burnett JR; van Bockxmeer FM; Hamilton S; Arnolda L; Watts GF
    Heart Lung Circ; 2008 Oct; 17(5):411-3. PubMed ID: 17683986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic tests for familial hypercholesterolemia.
    Day I; Humphries S
    Nat Biotechnol; 1996 Oct; 14(10):1227-8. PubMed ID: 9631083
    [No Abstract]   [Full Text] [Related]  

  • 11. Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia.
    Muller PY; Miserez AR
    Atheroscler Suppl; 2004 Dec; 5(5):1-5. PubMed ID: 15556092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia.
    Hopkins PN; Wu LL; Stephenson SH; Xin Y; Katsumata H; Nobe Y; Nakajima T; Hirayama T; Emi M; Williams RR
    J Hum Genet; 1999; 44(6):364-7. PubMed ID: 10570905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology of familial hypercholesterolemia].
    Pellicer Thoma E; Blanco Vaca F; Gómez Gerique JA
    An Med Interna; 1989 Mar; 6(3):154-61. PubMed ID: 2491193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is detection and treatment of familial hypercholesterolemia indicated in children?].
    Bakker HD; Wiegman A; Defesche JC; Kastelein JJ
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia.
    Urdal P; Leren TP; Tonstad S; Lund PK; Ose L
    Cytometry; 1997 Oct; 30(5):264-8. PubMed ID: 9383100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.